Sixteen brokerages covering Sweetgreen have assigned a consensus recommendation of Hold. Within that group, two analysts rate the shares as Sell, eleven as Hold and three as Buy. The average one-year target price stands at $11.43, based on the most recent updates over the past 12 months. Notable revisions include Zacks Research upgrading from Strong Sell to Hold on November 12 and UBS Group downgrading from Buy to Neutral with a $7.50 objective on January 6.

In its latest quarterly report, Sweetgreen posted revenue of $172.4 million, falling short of the $179.3 million analysts had forecast. The company reported a loss of $0.31 per share versus consensus expectations of a $0.18 loss. Same-store sales declined by 0.6% year-over-year, while negative return on equity reached 25.7% and net margin stood at negative 16.6%. Equities research analysts now project a full-year loss per share of $0.74.

Co-founders Nicolas Jammet and Jonathan Neman acquired 18,115 and 179,800 shares respectively on November 12, purchasing at average prices of $5.51 and $5.56. These insider purchases, totaling nearly $1.1 million in cash outlay, raised their individual ownership positions by infinite percentages and now represent 19.8% of total shares outstanding held by insiders.

Institutional investors and hedge funds own 95.8% of Sweetgreen’s outstanding shares. During the second quarter, Nisa Investment Advisors more than doubled its position to 2,129 shares and Skandinaviska Enskilda Banken increased to 2,808 shares. In the third quarter, Larson Financial Group lifted its stake by 165.8% to 3,766 shares and Bogart Wealth expanded its holdings by 1,150% to 5,000 shares. These moves reflect selective accumulation in recent months.